Literature DB >> 15141303

Expression of the Stp1 LMW-PTP and inhibition of protein CK2 display a cooperative effect on immunophilin Fpr3 tyrosine phosphorylation and Saccharomyces cerevisiae growth.

M Marchetta1, T Gamberi, S Sarno, F Magherini, G Raugei, G Camici, L A Pinna, A Modesti.   

Abstract

Although the yeast genome does not encode bona fide protein tyrosine kinases, tyrosine-phosphorylated proteins are numerous, suggesting that besides dual-specificity kinases, some Ser/Thr kinases are also committed to tyrosine phosphorylation in Saccharomyces cerevisiae. Here we show that blockage of the highly pleiotropic Ser/Thr kinase CK2 with a specific inhibitor synergizes with the overexpression of Stp1 low-molecular-weight protein tyrosine phosphatase (PTP) in inducing a severe growth-defective phenotype, consistent with a prominent role for CK2 in tyrosine phosphorylation in yeast. We also present in vivo evidence that immunophilin Fpr3, the only tyrosine-phosphorylated CK2 substrate recognized so far, interacts with and is dephosphorylated by Spt1. These data disclose a functional correlation between CK2 and LMW-PTPs, and suggest that reversible phosphorylation of Fpr3 plays a role in the regulation of growth rate and budding in S. cerevisiae.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141303     DOI: 10.1007/s00018-004-4019-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  7 in total

1.  In situ central pulmonary artery thrombosis in primary pulmonary hypertension.

Authors:  P P Agarwal; A L Wolfsohn; F R Matzinger; J M Seely; R A Peterson; C Dennie
Journal:  Acta Radiol       Date:  2005-11       Impact factor: 1.990

Review 2.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 3.  Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.

Authors:  Sindhu R Johnson; John T Granton; Sanjay Mehta
Journal:  Chest       Date:  2006-08       Impact factor: 9.410

4.  Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension.

Authors:  Agnès Tournier; Denis Wahl; Ari Chaouat; Jean-Pierre Max; Véronique Regnault; Thomas Lecompte; François Chabot
Journal:  Thromb Res       Date:  2010-12       Impact factor: 3.944

5.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

6.  Primary pulmonary hypertension: natural history and the importance of thrombosis.

Authors:  V Fuster; P M Steele; W D Edwards; B J Gersh; M D McGoon; R L Frye
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

7.  Primary pulmonary hypertension: a histopathologic study of 80 cases.

Authors:  J Bjornsson; W D Edwards
Journal:  Mayo Clin Proc       Date:  1985-01       Impact factor: 7.616

  7 in total
  4 in total

1.  Development and exploitation of CK2 inhibitors.

Authors:  Stefania Sarno; Maria Ruzzene; Pietrogiulio Frascella; Mario A Pagano; Flavio Meggio; Alfonso Zambon; Marco Mazzorana; Giovanni Di Maira; Vittorio Lucchini; Lorenzo A Pinna
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

2.  Solution structure of a low-molecular-weight protein tyrosine phosphatase from Bacillus subtilis.

Authors:  Huimin Xu; Bin Xia; Changwen Jin
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

3.  Lawsonia intracellularis LI0666 is a new EPIYA effector exported by the Yersinia enterocolitica type III secretion system.

Authors:  Cang Chen; Yimin Dai; Yingying Yang; Zihe Zhu; Qinghua Zhang; Xuejiao An; Fenju Lai
Journal:  Vet Res       Date:  2022-06-04       Impact factor: 3.829

4.  Identification and comparative analysis of sixteen fungal peptidyl-prolyl cis/trans isomerase repertoires.

Authors:  Trevor J Pemberton
Journal:  BMC Genomics       Date:  2006-09-22       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.